贾旭广,廖运宏,罗 兰

目的：探讨“双心医学”模式在尿毒症心肌病治疗中的疗效。方法：随机选取2022年1月-2023年06月宜宾市第三人民医院肾病风湿免疫科20例尿毒症心肌病患者，分组为对照组、实验组，每组10人。对照组采取传统治疗方法，实验组采取“双心医学”治疗模式，除了传统治疗方法外另外给予心理干预，2周后检测患者的脑钠肽、肌红蛋白、肌酸激酶同工酶、左室后壁厚度、左室射血分数等指标，了解“双心医学”治疗模式对患者心脏相关指标的影响。结果：实验组治疗后的脑钠肽、左室射血分数较对照组治疗后改善更加明显，具有显著的统计学意义（P＜0.05）。结论：“双心医学”治疗模式较传统治疗模式对尿毒症心肌病患者治疗效果更好，具备一定的推广价值。

双心医学；尿毒症心肌病；心理干预

[1]EdwardsNicolaC,MoodyWilliamE,ChueColinD,etal.Defining the natural history of uremic cardiomyopathy in chronic kidney disease:the role of cardiovascular magnetic resonance[J].JACCCard-iovascImaging,2014,7(7) :703-714.DOI:10.1016/j.jcmg.2013.09.025. [2]SempleD,SmithK,BhandariS,etal.Uremic cardiomyopathy and insulin resistance:A criticalrole fo rakt[J].Journal of the American Society of Nephrology,2011,22(2) :207-215.DOI:10.1681/ASN.2009090900. [3]陈灏珠.实用内科学[M].北京:人民卫生出版社,2013:2098－2107. [4]Peterson GE,de Backeb T,Contreras G,et al. Ｒelationship of left ventricular hypertrophy and diastolic function with cardiovascular and renal outcomes in African Americans with hypertensive chronic kidney disease[J]. Hypertension,2013,62(3):518 － 525. [5]FoleyRN,ParfreyPS,HarnettJD,etal.E:the prognostic importance of left ventricular geometry in uremic cardiomyopathy[J]. JAmSocNeph-rol,1995;5:2024-31. [6]TaylorD,BhandariS,SeymourAM.Mitochondrial dysfunction in uremiccardiomyopathy[J].AmJPhysiolRenalPhysiol,2015;308(6):F579 -87. [7]StoumposS,JardineAG,MarkPB.Cardiovascular morbidity and mortality after kidney transplantation[J].TransplantInternational, 2015,28(1) :10-21. [8]ZapolskiT,FurmagaJ,WysokińskiAP,etal.The atrial uremic cardiomyopathy regression in patients after kidney transplantation-the prospective echocardiographic study[J].BMCNephrol,2019,20(1) :152.DOI:10.1186/s12882-019-1333-y. [9]ＲiarSK,MitsnefesMM,NehusEJ,etal.Kidney transplantation in children with decreased left ventricular systolicfunction:a Midwest Pediatric Nephrology Consortiumstudy[J].PediatricNephrology,2015,30(8) :1343-1348.DOI:10.1007/s00467-015-3066-x. [10]段胜东.不同血液透析方法对维持性透析患者尿毒症毒素清除效果及营养状态的影响[J].实用临床医药杂志,2015,19(19) :26-29.DOI:10.7619/jcmp.201519008 [10]TyrallaK,AdamczakM,BenzK,etal.High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyop-athy[J].PLoSOne,2011,6(1) :e15287. [12]王伟铭,徐丽梨.钙离子拮抗剂类降压药在肾脏病中的合理应用[J].中华肾病研究电子杂志,2014,(5):251-254. [13]戴黎,周祖莲.β-受体阻滞剂在终末期肾脏病患者的应用推荐[J].疑难病杂志,2020,19(3). [14]刘志学,赵萌萌.事关身心,"双心医学"语境中的中西医"情志问题"访南昌大学第一附属医院吴印生教授[J].中国医药导报,2013,10(10):1-3 [15]于成,耿淑萍,孙怿泽.双心医学的中医研究现状[J].国医论坛,2017,32(2):68-70. [16]陈晓虎,朱贤慧,陈建东,等.双心疾病中西医结合诊治专家共识[J].中国全科医学,2017,20(14):1659-1662.

点击下载PDF